Stratagene is hoping that a US District Court judge in Texas will decrease the $7.8 million in damages a jury awarded to Invitrogen in a patent-infringement case, President and CEO Joe Sorge said during a conference call this week.
 
The Invitrogen case is one of several legal disputes in which Stratagene is embroiled and hopes to wrap up this year, either through final court rulings or settlements, according to Sorge.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.